

University of Michigan researchers discovered that combining two existing drugs significantly slowed the growth of treatment-resistant prostate cancer in lab and animal studies.

The breakthrough offers new hope for men with aggressive forms of the disease that no longer respond to standard treatments.

Want to know more?